BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10786694)

  • 1. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
    Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
    Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
    Zheng WH; Quirion R
    J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
    Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
    Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
    Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
    Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation.
    Boney CM; Smith RM; Gruppuso PA
    Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
    Boney CM; Gruppuso PA; Faris RA; Frackelton AR
    Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
    Calleja V; Ruiz Enríquez P; Filloux C; Peraldi P; Baron V; Van Obberghen E
    Endocrinology; 1997 Mar; 138(3):1111-20. PubMed ID: 9048617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
    Conejo R; Lorenzo M
    J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line.
    Tannheimer SL; Ethier SP; Caldwell KK; Burchiel SW
    Carcinogenesis; 1998 Jul; 19(7):1291-7. PubMed ID: 9683191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
    Leahy M; Lyons A; Krause D; O'Connor R
    J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.